Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments.
Business Model:
Revenue: $0
Employees: 0-0
Address: Nexus Building
City:
State: england
Zip: SG6 3TA
Country: GB
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments. Rosetta Capital Limited is based in London, United Kingdom.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2016 | Dilafor | Venture Round | 0 |
2/2006 | EyeSense AG | Series A | 0 |
2/2013 | Biosergen AS | Funding Round | - |
3/2013 | Asarina Pharma | Venture Round | - |
2/2014 | NovImmune | Series B | 0 |
9/2018 | Asarina Pharma | Post-IPO Equity | 0 |
2/2017 | Modus Therapeutics | Venture Round | 0 |
10/2010 | MerLion Pharma | Series C | 0 |
12/2022 | Carrick Therapeutics | Series C | 0 |
1/2013 | Aprea | Series A | - |
9/2018 | Asarina Pharma | Post-IPO Equity | 0 |
2/2017 | Modus Therapeutics | Venture Round | 0 |
9/2016 | Dilafor | Venture Round | 0 |
2/2014 | NovImmune | Series B | 0 |
3/2013 | Asarina Pharma | Venture Round | - |
2/2013 | Biosergen AS | Funding Round | - |
1/2013 | Aprea | Series A | - |
10/2010 | MerLion Pharma | Series C | 0 |
2/2006 | EyeSense AG | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|